新疆中泰化学股份有限公司2025年度拟不进行利润分配的公告深度解读
新疆中泰化学股份有限公司2025年度拟不进行利润分配的公告深度解读
要点概述
- 2025年度公司净利润亏损，董事会决议不进行现金红利分配、送红股或以公积金转增股本。
- 母公司2025年净利润为-4,124.99万元，但累计未分配利润仍高达59.49亿元。
- 合并报表显示公司连续三年净利润为负，2023-2025年均未分红。
- 公告强调公司将聚焦主业，推进降本增效和创新，力争减亏治亏，提升竞争力。
- 2025年度利润分配预案尚需股东大会审议通过。
- 本年度不分红方案未触及其他风险警示情形。
详细内容解读
新疆中泰化学股份有限公司（证券代码：002092，债券简称：23新化K1）于2026年3月24日召开的九届三次董事会审议通过了《2025年度利润分配预案》，拟定2025年度不进行利润分配。该预案尚需提交2025年度股东大会审议。
利润分配预案及原因
根据中兴华会计师事务所审计结果，母公司2025年净利润为-41,249,975.77元，年初未分配利润为5,990,613,658.35元，至2025年末母公司可供分配利润为5,949,363,682.58元。尽管累计未分配利润充足，但由于本年度出现净亏损，公司决定2025年度：
近三年分红及业绩情况
过去三年（2023-2025年），公司均未进行现金分红或回购注销操作。合并报表下，归属于上市公司股东的净利润分别为：
- 2023年：-2,865,037,237.87元
- 2024年：-976,515,443.22元
- 2025年：-288,750,432.86元
三年间平均净利润为-1,376,767,704.65元。2025年末合并报表累计未分配利润为5,054,134,059.19元，母公司报表为5,949,363,682.58元。
对投资者的影响及关键信息
- 连续三年未分红且持续亏损，显示公司盈利能力仍有较大压力，对股东回报存在影响，可能对投资信心和二级市场表现构成压力。
- 虽然累计未分配利润较高，但公司优先保障经营与资金需求，强调将通过降本增效、创新和开发高附加值产品来改善业绩。
- 本次不分红决定未触及深交所股票上市规则第9.8.1条第（九）项相关风险警示情形。
- 利润分配预案尚需股东大会审议，投资者可关注后续股东大会表决结果。
公司未来计划
公告中公司重申未来将坚持主责主业，采取多种措施降本增效，推进减亏治亏，提升创新质量，开发更具市场前景的产品，力争实现可持续发展并积极回报股东。
结论
对于关注分红政策和公司持续盈利能力的投资者而言，本次公告具有较强的价格敏感性。连续亏损与不分红决策反映公司正处于业绩修复期，短期内或对股价形成压力，但公司后续经营改善举措值得持续关注。
免责声明：本文内容仅供参考，不构成任何投资建议。投资者应结合自身情况谨慎决策，注意市场风险。
English Version:
Xinjiang Zhongtai Chemical Co., Ltd. 2025 Profit Distribution Plan: No Dividend and Detailed Analysis
Xinjiang Zhongtai Chemical 2025 Profit Distribution Plan: No Dividend and Implications for Investors
Key Highlights
- For 2025, the company posted a net loss and the board resolved not to pay dividends, not to issue bonus shares, nor to transfer capital reserve to share capital.
- Parent company’s net profit for 2025 was -41.25 million RMB, though cumulative undistributed profit remains high at 5.949 billion RMB.
- Consolidated results show three consecutive years of losses (2023-2025) with no dividend distributions.
- The company emphasizes focus on core business, cost optimization, and innovation, aiming to reduce losses and enhance competitiveness.
- The 2025 profit distribution plan is pending shareholders meeting approval.
- The no-dividend plan does not trigger any other risk warning conditions.
In-depth Analysis
Xinjiang Zhongtai Chemical Co., Ltd. (Stock code: 002092, Bond code: 23新化K1) held its 9th Board’s 3rd meeting on March 24, 2026, approving the 2025 profit distribution plan to not distribute profits for 2025. The plan is subject to approval at the 2025 annual shareholders meeting.
Profit Distribution Plan and Rationale
As audited by Zhongxinghua CPA, the parent company posted a net loss of 41.25 million RMB for 2025, with an opening cumulative undistributed profit of 5.991 billion RMB, resulting in a year-end cumulative undistributed profit of 5.949 billion RMB. Despite sufficient cumulative profits, due to net losses in 2025, the company proposes:
- No cash dividend distribution
- No bonus shares
- No capital reserve to share capital conversion
Three-Year Dividend and Performance Overview
In the past three years (2023-2025), the company neither paid cash dividends nor conducted any share buyback. Consolidated net profits attributable to shareholders were:
- 2023: -2.865 billion RMB
- 2024: -976.52 million RMB
- 2025: -288.75 million RMB
The three-year average net profit was -1.377 billion RMB. By the end of 2025, cumulative undistributed profit was 5.054 billion RMB (consolidated), and 5.949 billion RMB (parent).
Investor Impacts and Critical Information
- Three consecutive years without dividends and ongoing losses indicate significant pressure on profitability, which may negatively affect investor returns and confidence, and potentially impact market valuation.
- Despite large undistributed profits, the company prioritizes operations and funding needs, focusing on cost control, innovation, and the development of higher value-added products to improve results.
- The no-dividend proposal does not trigger the Shenzhen Stock Exchange listing rules risk warning (Article 9.8.1 (ix)).
- The plan is subject to shareholder approval—investors should watch for subsequent shareholder meeting outcomes.
Company Outlook
The company reiterates its commitment to its main business, cost reduction, innovation, and developing competitive products, aiming for sustainable growth and future shareholder returns.
Conclusion
This announcement is highly price-sensitive for investors focused on dividend policy and profitability. Continued losses and no dividend may pressure the share price in the short term, but ongoing operational improvement efforts warrant close attention.
Disclaimer: This article is for information purposes only and does not constitute investment advice. Investors should make decisions based on their own circumstances and be aware of market risks.
View 中泰化学 Historical chart here
